Hazel Daniels, PhD
@foresthazel.com
Forest pathologist working on #Phytophthora and fungal pathogens. An American transplant living the dream in Aotearoa. Intrests: unionism, #nzpol, corndogs, hammock naps. Opinions my own. #FreePalistine #ToitūTeTiriti
Very accurate as to the general feeling here. But lots of folks can't leave (or can hang on a bit longer). I hope the general election next year will help to shift this dark cloud.
November 28, 2025 at 11:15 PM
Very accurate as to the general feeling here. But lots of folks can't leave (or can hang on a bit longer). I hope the general election next year will help to shift this dark cloud.
Been here ~2 years, have seen redundancies every year since arriving. Not a great feeling!
November 26, 2025 at 9:14 AM
Been here ~2 years, have seen redundancies every year since arriving. Not a great feeling!
The show raises lots of interesting questions (many already discussed in other fine #pluribus threads)! I am curious if sentience helps or hinders their [obligate symbiont/pathogen] decision-making. I'm guessing the latter, evidenced by DHL individual's very expressive faces while chatting w/ Carol.
November 15, 2025 at 9:16 PM
The show raises lots of interesting questions (many already discussed in other fine #pluribus threads)! I am curious if sentience helps or hinders their [obligate symbiont/pathogen] decision-making. I'm guessing the latter, evidenced by DHL individual's very expressive faces while chatting w/ Carol.
Rest is an important part of the process!
November 13, 2025 at 6:40 PM
Rest is an important part of the process!
As a scientist who also (though now less) frequently uses em dashes, I can't wait for more people to come to this realisation!
November 4, 2025 at 6:18 PM
As a scientist who also (though now less) frequently uses em dashes, I can't wait for more people to come to this realisation!
Definitely disappointing news, yet I am glad we are still seeing news about low-performance trials. I desperately wish other fields of research were as open about 'negative results'!
October 24, 2025 at 6:54 PM
Definitely disappointing news, yet I am glad we are still seeing news about low-performance trials. I desperately wish other fields of research were as open about 'negative results'!